Recent developments include: •On January 6, 2012, the British Columbia Supreme Court granted an injunction against certain individuals from AlCana, ordering them to cease using Tekmira’s confidential information and return all of the documents taken from Tekmira. •On March 1, 2012, Tekmira filed a second Notice of Application in the British Columbia Supreme Court seeking to expand the injunction against these individuals to prohibit the use of any derivative or end products derived from Tekmira’s confidential information. •On February 15, 2012, primary document production was completed in the Massachusetts litigation against Alnylam and AlCana. The next phase of this case, depositions of fact witnesses, is to be completed by May 31, 2012. •A trial date of October 30, 2012 has been set in Massachusetts Superior Court for the litigation against Alnylam and AlCana.
“In sworn affidavits, the defendants in British Columbia admitted to taking confidential documents from Tekmira. After reviewing the stolen documents returned to us, we have confirmed that they contain Tekmira’s MC trade secrets, supporting our allegation that Tekmira’s confidential information was used to make MC3 from the Tekmira lipid MC2,” added Dr. Murray.